Results 131 to 140 of about 15,882 (175)

Prevalence of Cancer in Acid Sphingomyelinase Deficiency [PDF]

open access: yesJournal of Clinical Medicine, 2021
Acid sphingomyelinase deficiency (ASMD) is an inherited lysosomal disease characterised by a diffuse accumulation of sphingomyelin that cannot be catabolised into ceramide and phosphocholine. We studied the incidence of cancer in ASMD patients. We retrospectively reviewed the medical records of the adult chronic visceral ASMD patients in our cohort ...
Thierry Levade   +2 more
exaly   +4 more sources

Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disease caused by deficient activity of acid sphingomyelinase (ASM) enzyme, leading to the accumulation of varying degrees of sphingomyelin. Lipid storage leads to foam cell infiltration in tissues, and clinical features including hepatosplenomegaly, pulmonary insufficiency and in some ...
Andrea Elena Dardis   +2 more
exaly   +5 more sources

Acid Sphingomyelinase Deficiency Ameliorates Farber Disease [PDF]

open access: yesInternational Journal of Molecular Sciences, 2019
Farber disease is a rare lysosomal storage disorder resulting from acid ceramidase deficiency and subsequent ceramide accumulation. No treatments for Farber disease are clinically available, and affected patients have a severely shortened lifespan. We have recently reported a novel acid ceramidase deficiency model that mirrors the human disease closely.
Stephanie Kadow   +2 more
exaly   +5 more sources
Some of the next articles are maybe not open access.

Related searches:

Acid sphingomyelinase in macrophage apoptosis

Current Opinion in Lipidology, 2004
This article presents an overview of the recent progress in understanding metabolic and functional interrelationships of biologically active sphingolipids related to the sphingomyelin signal transduction pathway in relation to the regulation of apoptosis in macrophages.Ceramide generation is an essential, early step in apoptosis in numerous systems ...
Urs P, Steinbrecher   +2 more
openaire   +2 more sources

Acid Sphingomyelinase

2013
The enzyme acid sphingomyelinase catalyzes the hydrolysis of sphingomyelin to ceramide. The importance of the enzyme for cell functions was first recognized in Niemann-Pick disease type A and B, the genetic disorders with a massive accumulation of sphingomyelin in many organs. Studies in the last years demonstrated that the enzyme also has an important
Henry, Brian   +4 more
openaire   +3 more sources

The emerging role of Acid Sphingomyelinase in autophagy

Apoptosis, 2015
Autophagy, the main intracellular process of cytoplasmic material degradation, is involved in cell survival and death. Autophagy is regulated at various levels and novel modulators of its function are being continuously identified. An intriguing recent observation is that among these modulators is the sphingolipid metabolising enzyme, Acid ...
C. Perrotta   +6 more
openaire   +3 more sources

Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons [PDF]

open access: yesFrontiers in Physiology, 2014
Amitriptyline, a tricyclic antidepressant, has been used in the clinic to treat a number of disorders, in particular major depression and neuropathic pain. In the 1970s the ability of tricyclic antidepressants to inhibit acid sphingomyelinase (ASM) was discovered. The enzyme ASM catalyzes the hydrolysis of sphingomyelin to ceramide.
Deepa Sharma   +2 more
exaly   +5 more sources

Functional Inhibitors of Acid Sphingomyelinase (FIASMAs)

2013
Sphingolipids are not only structural components of biological membranes, but also play an important role in cellular signalling and, thus, are involved in cell proliferation and differentiation but also stress and cell death. It is therefore of great clinical relevance to define inhibitors of the enzymes involved in sphingolipid metabolism.
Kornhuber, Johannes   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy